Member Info for Mumbo_Jumbo

Nolupus,

Careful, the next stop for sng will be what sub 50 with mcap catching up with money in bank.

Eva,

Novacyte is the only true success, rest are pretenders who have fleeced investors and delivered very little income to date. They will all fall by they way side. Take AVCT for example... it had market cap of over £400 million last week!! Bonkers.

90% figure is BS. Not many have realised the potential dangers of an RNA vaccine down the line. Simply put, you are allowing the viral sequences to invade and replicate and then translated by your cellular machinery to produce the antigen to which the body mounts a response. Safety issues are being downplayed with regards to potential autoimmune disease.

RM is evading scrutiny here... £100 million raised in 2020 and yet to allow his peers to have a look at the data from July. it doesn’t inspire confidence with those that are in authority. that said, if he can pull his finger out and get the trail started ASAP now!! If he delays till 2021 then it makes me wonder if we have been played all along.

I apply little more caution... with so much going on at FDA, I wouldn’t be surprised if the timelines slipped.

How many volunteers encountered Covid at all? Maybe more from placebo came into contact with Covid and hence the 90% number.

Dacorum,

Directors sold stock here, when?

Bloodbath in AIM especially for Covid stocks.

Looks the wild ride has come to an end, courtesy of a massive ramping hype from Pfizer.

Maybe life in this dog yet if they can pull their finger out and get the trial completed ASAP.... before the end of Jan 2021.

It was in jest 1509, I don’t follow blindly.

Well done on your winning streak across multiple companies.

You are on roll mate.... well done!!

Had a quick peak at iq-ai couple of days ago... next time I am following you blindly LOL.

How long do they need to get by every year.... £3-5million? They have nothing else in the pipeline to throw money at from what I can see.

If the mcap is £100 -£150 million, it’s not a lot of money to raise, unless they go for broke and try to raise a silly amount. If they did the huge raise prior to results then that would a sure sign that the trial is not going well. But what would be the point in doing that raise, the company would have come to the end of the road with this drug for lupus.

If anyone from Avion IMM reading this board..... sequence all the genomes of the patients from the previous trial if you can especially the strongly positives from European and US along with the equal number of placebo, and see if there are common markers and use that to screen patients for the next trial. It maybe that case that it works well in a particular subset.

For me, the success will depend on finding the right population set it works well for. From previous trial, they have a clue. I really hope they Expand on this and have genomic data scientists scouring through their own as well as publicly available SLE patient genome data to find associations.

Thanks for the Woodstock. Need to get going quickly as possible whilst the hospitals are full of patients. I knows it’s macabre thinking...

Go back 7 months and this also has been a great success, especially if you invested early on in the year. But I think the market is now saturated with different manufacturers and the sale volumes are going to be tough to achieve.

You just got to hand it to the BOD of novacyt, they have been utterly superb and timed everything right. Pitty I didn’t back them.

When are we expecting results back the trials once it’s commenced..... 6 months?

Rossannan,

Ofcourse no one knows when and if it will be forthcoming. I am hoping that it will be sooner rather than later and putting money down in anticipation for it.

Eva,

Thanks. Evgen is like where SGN was back in March/April. The mcap is the attractive part. What are you thinking on SGN, I just have a gut feeling that it’s now a bull trap. Its not on the government’s radar with any of the large scale trials/studies they are supporting. There has to be a reason... which we are overlooking.

What would SPA do... I presume that’s where Avon will earn their keep. I will initiate first tranche this week.

I traded novavax from 25 to 80 something .... thought I done will. It peaked at high 180s!! Lol

Watching from sidelines.... And dithering in plunging here or in evgen? I know some of you are in both so what do you guys think will got north first.

Missed the rise in Synairgen earlier in the year waiting for the seller to clear .... and then it went bang!!